HIVPediatrics
Topics
Meeting category
Date(s)
15 Jul 2016 - 16 Jul 2016
Location
Durban, South Africa
Organizer
Platinum Level Support
Sponsor logos
ViiV Pediatrics
gilead

International Workshop on HIV & Pediatrics 2016

Related Enduring Materials

Slidesets
26
Videos
10
Enduring Materials
Session 1: Pediatric HIV Treatment and Prevention: Getting to 90-90-90 -
Chair
Elaine Abrams
Elaine Abrams, MD
Columbia University, United States
Pediatric HIV Treatment and Prevention: From Then to Now
Peter Mugyenyi
Peter Mugyenyi, MB ChB, FRCPI, FRCP
JCRC, Uganda
Slide set
Video
Path to the Future: New Guidelines, New Drugs, New Strategies -
Pediatric Drug Pipeline: New Drugs, New Strategies
Martina Penazzato
Martina Penazzato, MD, MSc, PhD
WHO, Switzerland
Slide set
Video
New WHO Guidelines on Breastfeeding
Nigel Rollins
Nigel Rollins
WHO, Switzerland
Slide set
Video
UNICEF Consultation: Countries Implementation of B+
Chewe Luo
Chewe Luo, MD, PhD
UNICEF, United States
Slide set
Video
Testing at Birth – Update from South Africa
Gayle Sherman
Gayle Sherman
U.Witwatersrand, South Africa
Slide set
Video
Treatment cascade of HIV-infected infants in Thailand National Program: how close are we to the 90-90-90 target?
Thanyawee Puthanakit
Thanyawee Puthanakit, MD
Chulalongkorn University, Thailand
Impact of the frequency of plasma viral load monitoring on treatment outcome among perinatally HIV-infected Asian children stable on first-line cART
Tavitiya Sudjaritruk
Tavitiya Sudjaritruk, MD, ScM, PhD
Chiang Mai University, Thailand
Virological response and resistance among HIV-infected children on first-line antiretroviral therapy without routine virological monitoring
Dr. Andrew Prendergast
-
Slide set
Session 2: Pediatric Antiretroviral Therapy -
Case Presentation
Moherndran Archary
Moherndran Archary, MBChB, PhD
University of KwaZulu Natal, South Africa
Case Presentation
Gareth Tudor-Williams
Gareth Tudor-Williams, MD
Imperial College London, United Kingdom
Access to antiretroviral initiation among HIV-infected children aged 0-19 years in the International Epidemiologic Databases to Evaluate AIDS Global Network
Dr. V. Leroy
-
Slide set
Switching to second-line antiretroviral therapy in HIV-infected children: a CIPHER cohort collaboration global analysis
Dr. R. Goodall
-
Slide set
Raltegravir (RAL) pharmacokinetics (PK) and safety in HIV-1-exposed neonates at high risk of infection (IMPAACT 1110)
Dr. D. Clarke
-
Slide set
HIV PCR testing at birth in KwaZulu Natal, South Africa – one year post introduction of the largest neonatal HIV testing programme
Dr. F. Moyo
-
Slide set
Paediatric HIV point of care testing: field evaluation of the performance of Cepheid and Alere qualitative HIV assays in a Soweto academic hospital
Dr. T. Murray
-
Slide set
Session 3: Adolescent Transition to Adult Care: What Do We Know and What Are the Research Priorities -
Chair
Sohn, 2022
Annette Sohn, MD, PhD
TREAT Asia/amfAR, Thailand
High-Resource Perspective on Adolescent Transition and Research Priorities
Ali Judd
Ali Judd
University College London, UK
Slide set
Video
Low-Resource Perspective on Adolescent Transition and Research Priorities
Mary-Ann Davies
Mary-Ann Davies, MBChB, MMed, PhD, FC
University of Cape Town, South Africa
Slide set
Video
The global epidemiology of perinatally HIV-infected adolescents: A CIPHER Global Cohort Collaboration analysis
Dr. Amy Slogrove
-
Slide set
What does adolescent transition mean in sub-Saharan Africa? Predictors of transfer in Southern African perinatally HIV-infected adolescents
Mary-Ann Davies
Mary-Ann Davies, MBChB, MMed, PhD, FC
University of Cape Town, South Africa
Session 4: Managing Children and Youth with HIV -
Chair
Jason Brophy
Jason Brophy, MD, MSc, DTM, FRCPC
Children's Hospital of Eastern Ontario, Canada
It’s Not Just HIV: Complications and Research Priorities in Care of HIV-Infected Youth
Rashida Ferrand
Rashida Ferrand, FRCP, PhD, FMed Sci
London School of Hygiene & Tropical Medicine, United Kingdom / Biomedical Research and Training Institute, Zimbabwe
Slide set
Video
Higher retention and viral suppression rates in dedicated adolescent-friendly HIV clinic in South Africa
Brian Zanoni, MD, MPH
-
Slide set
Decreased bone turnover in HIV-infected children on antiretroviral therapy
Dr. S. Shiau
-
Slide set
Efficacy of the Amagugu intervention to increase maternal HIV disclosure to HIV-uninfected primary school aged children in Southern Africa: a randomized controlled tria
Dr. T.J. Rochat
-
Session 5: Optimizing Diagnosis of HIV Infection in Infants and Children -
Chair
Victor Musiime
Tsungai Chipato, MBChB
University of Zimbabwe College of Health Sciences, Zimbabwe
Comparing Point of Care to Laboratory HIV PCR testing at birth in a hospital setting in Johannesburg, South Africa
Dr. K.G. Technau
-
Does HIV DNA-PCR testing of HIV-exposed infants at birth reduce follow-up for routine testing at 4-14 weeks of age?
Dr. E. Kalk
-
Slide set
Impact of birth HIV PCR testing on routine 6-week EID testing in Cape Town, South Africa
Dr. L. Dunning
-
Slide set
Where have all the children gone? High HIV prevalence in infants attending nutrition and inpatient wards
Dr. C. Kiyaga
-
Slide set
Debate: PrEP Should Be Offered to All Sexually Active Adolescents for Prevention -
Chair
Diana Gibb
Diana Gibb, MD, MRCP, MSc
Medical Research Council Clinical Trials Unit, United Kingdom
Debate: PrEP Should Be Offered to All Sexually Active Adolescents for Prevention PRO
Linda-Gail Bekker 2021
Linda-Gail Bekker, MBChB, DTMH, DCH, FCP(SA), PhD
Desmond Tutu Health Foundation / University of Cape Town (UCT), South Africa
Debate: PrEP Should Be Offered to All Sexually Active Adolescents for Prevention CON
Lynne Mofenson
Lynne Mofenson, MD
Elizabeth Glaser Pediatric AIDS Foundation, United States
Session 6: Prevent of Mother-To-Child-Transmission in the Treatment Era -
Option B+: Beyond ART – Experience with Retention and Outcomes
Landon Myer
Landon Myer
University of Cape Town, South Africa
Slide set
Video
Maternal Triple Antiretrovirals (mART) and Infant Nevirapine (iNVP) Prophylaxis for the Prevention of Mother-to-Child Transmission (MTCT) of HIV during Breastfeeding (BF)
Dr. T. Taha
-
Outcomes of HIV-exposed infants before and after implementing Option B+ PMTCT guidelines in Kampala, Uganda: a retrospective cohort study
Dr. P. Elyanu
-
Slide set
Impact of tenofovir-containing triple antiretroviral therapy (ART) on bone mineral density in HIV-infected breastfeeding women in sub-Saharan Africa
Dr. L. Stranix
-
Slide set
Session 7: Coinfections and Complications of HIV in Children -
Chair
Mark Cotton
Mark Cotton, MD, PhD
Tygerberg Children’s Hospital (TCH), Stellenbosch University (SU), South Africa
The Challenge of Drug-Resistant TB in Children with HIV
Simon Schaaf
Simon Schaaf, MMed, PhD
Tygerberg Children’s Hospital, South Africa
Slide set
Video
Lung function in HIV-infected South African adolesents on antiretroviral therapy: the Cape Town adolescent antiretroviral cohort
Dr. L. Githinji
-
Slide set
Long-term neurodevelopmental outcomes on early limited or deferred continuous antiretroviral therapy: evidence from the CHER trial
Dr. B. Laughton
-
Neuropsychological performance in African HIV children in a multi-site ARV clinical trial is poorer than non-infected children
Dr. M. Boivin
-
Slide set
Session 8: Joint Session HIV Pediatric Workshop and HIV Cure Workshop: Towards an HIV Cure in Children -
Chair
Debbie Persaud
Debbie Persaud, MD
Johns Hopkins University School of Medicine, USA
Neonatal and Pediatric Immunology Relevant to HIV Persistence
Nigel Klein
Nigel Klein, MRCP, PhD
University College London, UK
placeholder3
Deena Gibbons
Kings College London, UK
Overview
Welcome

With well over 200 participants joining us for this meeting, we are very pleased to look back on an incredibly successful 8th International Workshop on HIV Pediatrics held in Durban, South Africa on 15 and 16 July, prior to the 21st International AIDS Conference (AIDS2016).

The Organizing Committee and the Organizing Secretariat would like to thank the invited speakers and all participants for their contribution to this meeting! In particular we would like to thank our workshop sponsors: ViiV/Paediatrics, Janssen Pharmaceutica NV, NIH/NIAID, Mylan, Penta, Siemens Healthineers, Unicef, and Roche. Without their financial contribution this workshop would not have been made possible.

Chairs 2016
Language
Related Programs
Afbeelding
Karin
Caption
Hi! I’m Karin
Label / Name
How can I help you?
Go to Contact form webform